Coston McIsaac & Partners’s Eli Lilly LLY Stock Holding History

Coston McIsaac & Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$636K	Buy	530 +1	+0.2%	+$1.02K	0.13%	83
2026 Q1	$486K	Hold	529	–	–	0.11%	82
2025 Q4	$568K	Buy	529 +1	+0.2%	+$956	0.13%	81
2025 Q3	$403K	Hold	528	–	–	0.1%	93
2025 Q2	$412K	Buy	528 +12	+2%	+$9.32K	0.11%	93
2025 Q1	$426K	Sell	516 -3	-0.6%	-$2.5K	0.12%	84
2024 Q4	$400K	Buy	519 +2	+0.4%	+$1.66K	0.12%	89
2024 Q3	$458K	Buy	517 +1	+0.2%	+$899	0.13%	84
2024 Q2	$467K	Hold	516	–	–	0.15%	75
2024 Q1	$401K	Buy	516 +1	+0.2%	+$712	0.13%	84
2023 Q4	$300K	Hold	515	–	–	0.1%	89
2023 Q3	$276K	Sell	515 -23	-4%	-$11.9K	0.1%	86
2023 Q2	$252K	Hold	538	–	–	0.09%	102
2023 Q1	$184K	Buy	538 +157	+41%	+$53K	0.07%	113
2022 Q4	$139K	Hold	381	–	–	0.05%	143
2022 Q3	$123K	Hold	381	–	–	0.06%	136
2022 Q2	$124K	Buy	+381	New	+$114K	0.07%	89

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coston McIsaac & Partners's LLY Position: Q2 2026 in Review

Coston McIsaac & Partners increased its Eli Lilly (LLY) stake by 0.19% in Q2 2026, buying an estimated $1.02K and bringing the position to 530 shares worth $636K. The position accounts for 0.13% of the portfolio, ranked #83.

Coston McIsaac & Partners first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Coston McIsaac & Partners held 530 shares of Eli Lilly worth $636K as of Q2 2026.
Coston McIsaac & Partners bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
Eli Lilly made up 0.13% of Coston McIsaac & Partners's portfolio in Q2 2026, its #83 holding.
Coston McIsaac & Partners first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.